Skip to main content

Novavax CEO contends COVID vaccine is 'more stable' than alternatives, could reduce 'all disease'

Novavax President and CEO Stanley Erck tells 'Cavuto: Coast to Coast' their COVID vaccine does 'very well' against the Beta, Delta and Omicron variants.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.